31-05-2026 18:07
via
nytimes.com
China’s Rise in Drug Development Looms Over U.S.
Clinical trials in China are getting attention at an international oncology gathering in Chicago. China’s surging biotechnology industry is fueling alarm that U.S. dominance in the field is waning.
Read more »
Biotechnology news
Programmable mycolysins expand the antimicrobial toolkit against mycobacteria
The New Race to Find Treatments for Measles
With Measles Roaring Back, the Search for a Drug is On
Better Sex, Better Hair, Better Sleep: ‘Humanmaxxing’ Is Here
As Ebola Spreads in East Africa, Will China Step Up?
Reprogramming halophilic life for low-salt biomanufacturing
Biotechnologies based on the fungal bioluminescence pathway
Blue at the edge
The Rich and Powerful Want to Live Forever
Scientific breakthrough versus successful startup: teaching scientists to navigate bench to business
Engineered phage-derived lysins effectively kill mycobacterial pathogens
Clinical-scale bioreactor production of hiPSC-derived extracellular vesicles modulates miRNA and protein cargo to enhance angiogenic function
Synthetic M13 phage engagers expand CAR-T cell antigen recognition to overcome tumor heterogeneity
How to Turn a Chicken Egg Into a Drug Factory
Desktop versie